← All stocks

ALX ONCOLOGY HOLDINGS INC

ALXO Net buying
CIK 0001810182 #3671 in the set updated 17 Sep 2026
Bought (120 mo)
$91.65M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$41.82M
$414.37K on a plan · $9.57M straight out of an exercise
Sold at will
$31.84M
148 of 188 sales
Net
+$49.83M
+$59.81M against sales at will

By person

14 insiders · 224 transactions
1.8×

Jason Lettmann holds only 1.8 times base salary in stock. $1.35M of shares against $724.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Jason Lettmann last reported holding, valued at $1.93, the price Common Stock was last bought or sold at on the open market here, on 17 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
GOODMAN COREY S
Director
$21.15M (2)
+$21.15M
8,914,849
$17.21M
Graham G. Walmsley
Director
$20.05M (2)
+$20.05M
2,161,981
$4.17M
Vivo Capital IX, LLC entity
10% owner
$18.53M (2)
+$18.53M
185,526
$358.07K
Adelman Robert J
10% owner
$16.21M (2)
+$16.21M
5,829,542
$11.25M
Pons Jaume
PRESIDENT & CSO
$10.84M (47)
−$10.84M
579,388
$1.12M
+9.1%
GARCIA PETER S
CHIEF FINANCIAL OFFICER
$159.34K (2)
$6.57M (28) scheduled
−$6.41M
121,516
$234.53K
+2,066%
Lettmann Jason
CHIEF EXECUTIVE OFFICER
$7.75M (5)
$13.63M (32)
−$5.89M
700,547
$1.35M
Randolph Sophia
CHIEF MEDICAL OFFICER
$4.64M (34)
−$4.64M
325,711
$628.62K
+56.2%
LSV Associates, LLC entity
10% owner
$7.60M (2)
$5.99M (28)
+$1.61M
406,168
$783.90K
Wong Shelly
SVP, FINANCE AND CAO
$158.01K (19)
−$158.01K
87,828
$169.51K
+487.5%
Hemrajani Rekha
Director
$103.40K (2)
+$103.40K
33,000
$63.69K
Shantharam Harish
Chief Financial Officer
$58.40K (1)
+$58.40K
75,000
$144.75K
Pietzke Steffen
VP Fin & Chief Acct Officer
$57.00K (1)
+$57.00K
3,000
$5.79K
Caffo Nathan
Chief Business Officer
11,254
$21.72K
+1,452%

No percentages here. This company's share count has moved by a factor of 2.6 over the window, from 52,743,104 to 138,276,997 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
GOODMAN COREY S
2 Feb 2026
Director
Buy indirect
3,184,713
$1.57
$5.00M
Lettmann Jason
17 Sep 2025
CHIEF EXECUTIVE OFFICER
Buy
71,163
$1.08
$76.89K
Lettmann Jason
16 Sep 2025
CHIEF EXECUTIVE OFFICER
Buy
21,070
$1.07
$22.46K
Shantharam Harish
18 Aug 2025
Chief Financial Officer
Buy
75,000
$0.78
$58.40K
Hemrajani Rekha
2 Dec 2024
Director
Buy
30,000
$1.55
$46.40K
GARCIA PETER S
13 Jun 2024
CHIEF FINANCIAL OFFICER
Buy
12,000
$8.53
$102.34K
Lettmann Jason
14 Mar 2024
CHIEF EXECUTIVE OFFICER
Buy
4,400
$11.31
$49.77K
Graham G. Walmsley
14 Dec 2020
Director
Buy indirect
20,000
$76.00
$1.52M
GARCIA PETER S
21 Jul 2020
Chief Financial Officer
Buy
3,000
$19.00
$57.00K
Pietzke Steffen
21 Jul 2020
VP Fin & Chief Acct Officer
Buy
3,000
$19.00
$57.00K
GOODMAN COREY S
21 Jul 2020
Director
Buy indirect
850,000
$19.00
$16.15M
Hemrajani Rekha
21 Jul 2020
Director
Buy
3,000
$19.00
$57.00K
Graham G. Walmsley
21 Jul 2020
Director
Buy indirect
975,000
$19.00
$18.53M
Vivo Capital IX, LLC
21 Jul 2020
10% owner
Buy indirect
185,526
$19.00
$3.52M
Vivo Capital IX, LLC
21 Jul 2020
10% owner
Buy indirect
789,474
$19.00
$15.00M
Adelman Robert J
21 Jul 2020
10% owner
Buy
3,000
$19.00
$57.00K
Adelman Robert J
21 Jul 2020
10% owner
Buy indirect
850,000
$19.00
$16.15M
Lettmann Jason
21 Jul 2020
Director
Buy indirect
22,000
$19.00
$418.00K
Lettmann Jason
21 Jul 2020
Director
Buy indirect
378,000
$19.00
$7.18M
LSV Associates, LLC
21 Jul 2020
10% owner
Buy indirect
22,000
$19.00
$418.00K
LSV Associates, LLC
21 Jul 2020
10% owner
Buy indirect
378,000
$19.00
$7.18M

What was left out

Form 4 filings counted 187
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 37
Sales at will 148
Transactions with no price 0
Shares from compensation/vesting 28,133,470
Sales filed before the plan box existed 114
History held since 17 Jul 2020